Compounds > dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination
Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infections, Respiratory Syncytial Virus

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Infections, Respiratory Syncytial Virus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gebara, BM; Kroupa-Kulik, M1

Other Studies

1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infections, Respiratory Syncytial Virus

ArticleYear
Surfactant administration in severe hypoxic respiratory failure due to respiratory syncytial virus.
    Clinical pediatrics, 1999, Volume: 38, Issue:4

    Topics: Drug Combinations; Fatty Alcohols; Female; Humans; Infant; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Syncytial Virus Infections; Treatment Outcome; Ventilators, Mechanical

1999